Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen

Showing results (631-640 of 270,837) with videos related to

Pageof 27,084
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|May 17, 2011
President obama reopens debate on patented biologics: will the FDA quickly define an abbreviated pathway for biosimilars?Stephen Barlas
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|March 2, 2011
Descent with modification and the archaeological recordStephen Shennan
Seminars in Interventional Radiology|March 2, 2011
Interventional radiology in the austere environmentStephen Ferrara
Health Affairs (Project Hope)|October 7, 2011
'Super committee' looks to health for savings to reduce deficitsStephen Langel
British Dental Journal|October 8, 2011
Fair commentStephen Hancocks
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 2011
The major cause of multiple sclerosis is environmental: genetics has a minor role--noStephen Sawcer
Cell Host & Microbe|July 20, 2011
Another target for NOStephen Spiro
Environmental Toxicology and Pharmacology|July 26, 2011
Can cholinesterase inhibitors affect neural development?Stephen Brimijoin
Current Opinion in Critical Care|August 17, 2011
Critical care outcomes: current and future issuesStephen Brett
The Hastings Center Report|August 18, 2011
Dead rightsStephen Bates
Pageof 27,084

Showing results (631-640 of 270,837) with videos related to

Sort By:
Pageof 27,084
P & T : a Peer-Reviewed Journal for Formulary Management|May 17, 2011
President obama reopens debate on patented biologics: will the FDA quickly define an abbreviated pathway for biosimilars?Stephen Barlas
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|March 2, 2011
Descent with modification and the archaeological recordStephen Shennan
Seminars in Interventional Radiology|March 2, 2011
Interventional radiology in the austere environmentStephen Ferrara
Health Affairs (Project Hope)|October 7, 2011
'Super committee' looks to health for savings to reduce deficitsStephen Langel
British Dental Journal|October 8, 2011
Fair commentStephen Hancocks
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 2011
The major cause of multiple sclerosis is environmental: genetics has a minor role--noStephen Sawcer
Cell Host & Microbe|July 20, 2011
Another target for NOStephen Spiro
Environmental Toxicology and Pharmacology|July 26, 2011
Can cholinesterase inhibitors affect neural development?Stephen Brimijoin
Current Opinion in Critical Care|August 17, 2011
Critical care outcomes: current and future issuesStephen Brett
The Hastings Center Report|August 18, 2011
Dead rightsStephen Bates
Pageof 27,084